NITRIC-OXIDE (NO) IS AN ENDOGENOUS ANTICONVULSANT BUT NOT A MEDIATOR OF THE INCREASE IN CEREBRAL BLOOD-FLOW ACCOMPANYING BICUCULLINE-INDUCED SEIZURES IN RATS
Q. Wang et al., NITRIC-OXIDE (NO) IS AN ENDOGENOUS ANTICONVULSANT BUT NOT A MEDIATOR OF THE INCREASE IN CEREBRAL BLOOD-FLOW ACCOMPANYING BICUCULLINE-INDUCED SEIZURES IN RATS, Brain research, 658(1-2), 1994, pp. 192-198
Neurons synthesize NO, which may act as a retrograde messenger, involv
ed in either potentiating or depressing neuronal excitability. NO may
also play a role in the cerebral vasodilatory response to increased ne
uronal activity (i.e., seizures). In this study, two questions were as
ked: (1) is NO an endogenous anticonvulsant or proconvulsant substance
? and (2) is the cerebral blood flow (CBF) increase accompanying bicuc
ulline (BC)-induced seizures mediated by NO? The experiments were perf
ormed in 300-400-g Wistar rats anesthetized with 0.6% halothane and 70
% N2O/30% O-2. CBF was measured using the intracarotid Xe-133 clearanc
e method or laser-Doppler flowmetry. EEG activity was recorded. Chroni
c treatment (4 days) with nitro-L-arginine (L-NA), a potent NO synthas
e (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and
prolonged seizure duration from 6 +/- 1 (saline-treated controls) to
12 +/- 2 min. In the L-NA-treated group, the CBF increase was sustaine
d as long as seizure activity remained, indicating that CBF was still
tightly coupled to seizure activity. Interestingly, the supposed inact
ive enantiomer of L-NA, D-NA, also showed an inhibition of brain NOS a
ctivity, ranging from 87 to 100%. The duration of seizures in this gro
up (average 8 +/- 2 min) corresponded directly to the magnitude of red
uction in NOS activity (r = 0.83, P < 0.05). Specifically, the D-NA re
sults indicated that NOS inhibition had to exceed 95% before any effec
t on seizure duration could be seen. Additional results demonstrated t
hat only a total dose of 400 mg/kg of L-NA, given chronically was capa
ble of prolonging the BC-induced CBF increase. With acute doses of 5 a
nd 30 mg/kg L-NA, the time course of CBF changes after BC administrati
on was not different from the control. These findings suggest that end
ogenous NO acts as an anticonvulsant perhaps via a negative feedback m
echanism at the NMDA receptor. NO, however, does not appear to couple
neuronal activation to increased CBF in this model.